oxazoles has been researched along with Down Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casero, JL; d'Ardhuy, XL; Derks, M; Fontoura, P; Goeldner, C; Hernandez, MC; Hipp, JF; Khwaja, O; Kishnani, PS; Lennon-Chrimes, S; Noeldeke, J; Pellicer, S; Skotko, BG; Squassante, L; Visootsak, J; Wandel, C | 1 |
1 trial(s) available for oxazoles and Down Syndrome
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABA
Topics: Adolescent; Child; Child, Preschool; Down Syndrome; gamma-Aminobutyric Acid; Humans; Intellectual Disability; Morpholines; Oxazoles; Pyridines; Quality of Life; Treatment Outcome; Young Adult | 2022 |